These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18973496)

  • 21. Case report: adenosine induced ventricular fibrillation in a patient with stable ventricular tachycardia.
    Parham WA; Mehdirad AA; Biermann KM; Fredman CS
    J Interv Card Electrophysiol; 2001 Mar; 5(1):71-4. PubMed ID: 11248777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenosine-induced worsening of supraventricular tachycardia.
    Kunnumpuram GK; Patel A
    BMJ Case Rep; 2012 Dec; 2012():. PubMed ID: 23230260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Five paediatric case reports of the use of adenosine in supraventricular tachycardia.
    Koh E; Chan I; Wong KY
    Ann Acad Med Singap; 1998 May; 27(3):363-5. PubMed ID: 9777081
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness and safety of adenosine in the therapy and diagnosis of arrhythmias].
    Dúbrava J; Jurkovicová O
    Vnitr Lek; 2003 Apr; 49(4):267-72. PubMed ID: 12793048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of oral flecainide acetate in patients with cardiac arrhythmias.
    Nakazato Y; Nakata Y; Yasuda M; Nakazato K; Sumiyoshi M; Ogura S; Yamaguchi H
    Jpn Heart J; 1997 May; 38(3):379-85. PubMed ID: 9290572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
    Chimienti M; Cullen MT; Casadei G
    Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Supraventricular tachyarrhythmias. Cardiac, extra-cardiac and arrhythmogenic side effects of anti-arrhythmia drugs].
    Meinertz T; Willems S; Weiss C
    Internist (Berl); 1998 Jan; 39(1):33-7. PubMed ID: 9530568
    [No Abstract]   [Full Text] [Related]  

  • 28. [Exogenous adenosine as an anti-arrhythmia agent].
    Tebbenjohanns J; Pfeiffer D; Schumacher B; Korte T; Jung W; Lüderitz B
    Z Kardiol; 1996; 85 Suppl 6():191-9. PubMed ID: 9064965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adenosine versus verapamil in the treatment of supraventricular tachycardia: a randomized double-crossover trial.
    Hood MA; Smith WM
    Am Heart J; 1992 Jun; 123(6):1543-9. PubMed ID: 1595533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocardiographic correlates of spontaneous termination of ventricular tachycardia in patients with coronary artery disease.
    Duff HJ; Mitchell LB; Gillis AM; Sheldon RS; Chudleigh L; Cassidy P; Chiamvimonvat N; Wyse DG
    Circulation; 1993 Sep; 88(3):1054-62. PubMed ID: 8353867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of out-of-hospital supraventricular tachycardia: adenosine vs verapamil.
    Brady WJ; DeBehnke DJ; Wickman LL; Lindbeck G
    Acad Emerg Med; 1996 Jun; 3(6):574-85. PubMed ID: 8727628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias.
    Rankin AC; Oldroyd KG; Chong E; Rae AP; Cobbe SM
    Br Heart J; 1989 Sep; 62(3):195-203. PubMed ID: 2789911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine-induced ventricular fibrillation.
    Shah CP; Gupta AK; Thakur RK; Hayes OW; Mehrotra A; Lokhandwala YY
    Indian Heart J; 2001; 53(2):208-10. PubMed ID: 11428480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Verapamil or adenosine for the immediate treatment of supraventricular tachycardia.
    Rankin AC; Rae AP; Oldroyd KG; Cobbe SM
    Q J Med; 1990 Feb; 74(274):203-8. PubMed ID: 2345787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenosine-induced atrial arrhythmia: a prospective analysis.
    Strickberger SA; Man KC; Daoud EG; Goyal R; Brinkman K; Knight BP; Weiss R; Bahu M; Morady F
    Ann Intern Med; 1997 Sep; 127(6):417-22. PubMed ID: 9312997
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenosine-induced severe bronchospasm in a patient without pulmonary disease.
    Coli S; Mantovani F; Ferro J; Gonzi G; Zardini M; Ardissino D
    Am J Emerg Med; 2012 Nov; 30(9):2082.e3-5. PubMed ID: 22177587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenosine and supraventricular tachycardia.
    DiMarco JP
    Prog Clin Biol Res; 1987; 230():271-81. PubMed ID: 3588601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosine: novel antiarrhythmic therapy for supraventricular tachycardia.
    Nagelhout JJ
    AANA J; 1992 Jun; 60(3):287-92. PubMed ID: 1632157
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External cardiac programmed stimulation for noninvasive termination of sustained supraventricular and ventricular tachycardia.
    Estes NA; Deering TF; Manolis AS; Salem D; Zoll PM
    Am J Cardiol; 1989 Jan; 63(3):177-83. PubMed ID: 2909997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias.
    Wehling M
    Arzneimittelforschung; 2002; 52(7):507-14. PubMed ID: 12189773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.